Liu Christina Y, Elias Kevin M, Howitt Brooke E, Lee Larissa J, Feltmate Colleen M
Harvard Medical School, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA.
Gynecol Oncol. 2017 May;145(2):248-255. doi: 10.1016/j.ygyno.2017.03.012. Epub 2017 Mar 28.
To examine the effects of universal sentinel lymph node mapping on the use of nodal staging in endometrial adenocarcinoma.
Two approaches to laparoscopic staging for endometrial adenocarcinoma were compared using a before and after study design. The before cohort underwent selective lymphadenectomy from January 1, 2014-October 1, 2015 while the after cohort underwent universal sentinel lymph node (SLN) mapping from October 2, 2015-September 29, 2016.
The before cohort comprised 215 patients and the after cohort 166 patients. In women undergoing SLN mapping, a sentinel node was identified at least unilaterally in 146/153 cases (95.4%), and bilaterally in 114/153 (74.5%) of cases. Pelvic nodes were removed in 35.8% of the before cohort versus 92.2% of the after cohort (p<0.0001) with more nodal evaluation among both low risk (9.6% vs. 91%, p<0.0001) and high risk cases (66% vs. 94%, p<0.0001). While the proportion of low risk cases diagnosed with nodal involvement did not significantly change (0.9% to 3.1%, p=0.32), there was a trend toward more diagnoses of nodal involvement in high risk cases (5% to 13.2%, p=0.06). Mean number of pelvic lymph nodes removed (15 vs. 4, p<0.0001), mean operative time (181min vs. 137min, p<0.0001), estimated blood loss (80ml vs. 56ml, p=0.004), and rate of post-operative complications (13% vs. 5.2%, p=0.04) all decreased after the adoption of SLN dissection.
Universal sentinel lymph node dissection for laparoscopic endometrial cancer staging reduces heterogeneity in surgeon staging practice, increases nodal detection, and lowers post-operative complications.
探讨通用前哨淋巴结定位对子宫内膜腺癌淋巴结分期应用的影响。
采用前后对照研究设计,比较两种腹腔镜下子宫内膜癌分期方法。前一组在2014年1月1日至2015年10月1日期间接受选择性淋巴结切除术,而后一组在2015年10月2日至2016年9月29日期间接受通用前哨淋巴结(SLN)定位。
前一组包括215例患者,后一组包括166例患者。在接受SLN定位的女性中,至少单侧发现前哨淋巴结的有146/153例(95.4%),双侧发现的有114/153例(74.5%)。前一组35.8%的患者切除了盆腔淋巴结,而后一组为92.2%(p<0.0001),低风险(9.6%对91%,p<0.0001)和高风险病例(66%对94%,p<0.0001)中的淋巴结评估更多。虽然诊断为淋巴结受累的低风险病例比例没有显著变化(0.9%至3.1%,p=0.32),但高风险病例中淋巴结受累的诊断有增加趋势(5%至13.2%,p=0.06)。采用SLN清扫术后,盆腔淋巴结切除的平均数量(15个对4个,p<0.0001)、平均手术时间(181分钟对137分钟,p<0.0001)、估计失血量(80毫升对56毫升,p=0.004)和术后并发症发生率(13%对5.2%,p=0.04)均有所下降。
用于腹腔镜子宫内膜癌分期的通用前哨淋巴结清扫术减少了外科医生分期实践中的异质性,增加了淋巴结检测,并降低了术后并发症。